SpineGuard will launch PediGuard Threaded DSG™ device at “SpineWeek 2016” world conference in Singapore

PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard
(FR0011464452 – ALSGD), an innovative company that develops and markets
disposable medical devices designed to make spine surgery safer,
announced today the commercial launch of its new PediGuard Threaded
device at the occasion of the “SpineWeek 2016” world conference which is
scheduled to take place in Singapore from May 16 to May 20. This launch
follows successful clinical evaluations performed by seven surgical
teams in Europe and Asia.
« As a regular user of the DSG™ technology, I particularly appreciate
the PediGuard Threaded device because this novel « three in one »
instrument enables me to optimize both the insertion, the positioning
and the anchorage of screws into the vertebra without the need for
fluoroscopy,” said Ciaran Bolger, M.D., Neurosurgeon, Dublin, Ireland.
Pierre Jérôme, CEO and co-founder of SpineGuard, added: « PediGuard
Threaded completes our range of smart drilling devices whose clinical
value keeps on being reinforced by new studies in terms of implant
placement accuracy, x-ray exposure diminution and OR time-reduction.
Three of them will be presented next week by eminent spine surgeons at
the SpineWeek world conference in Singapore. »
Eighteen major international spine societies come together every four
years during the SpineWeek conference. Between 3,500 and 4,000
orthopedists and neurosurgeons are expected from all over the world next
week in Singapore where the DSG™ technology will be featured in three
scientific podium presentations listed below:
Monday May 16^th
Accuracy
of a Dynamic Surgical Guidance (DSG™) probe for screw insertion in the
cervical spine
Dixon D., Darden B., Casamitjana J., Weismann
K., Powell D., Baluch D. (USA, Spain & Chile)
Tuesday May 17^th
Does
the use of Dynamic Surgical Guidance (DSG™) assist with accurate pedicle
screw placement in patients with osteoporosis or osteopenia? Defino
H., Williams J., da Silva Herrero C.F., Betz R., Powell D., Gaughan J.
(Brazil & USA)
Thursday May 19^th
Reducing
pedicle drilling radiation by using Dynamic Surgical Guidance (DSG™)
with a Jamshidi needle while maintaining screw placement accuracy Williams
J., Khoo L., Gaughan J., Betz R. (USA)
Recent events:

Latest media article:
Becker
Spine How value-based spine care shapes technology development: Key
thoughts on SpineGuard (March 31)
Next financial press release: 2016 Half-year revenue: July 12, 2016
About SpineGuard®
Co-founded in 2009 in France and the USA by Pierre Jérôme and Stéphane
Bette, SpineGuard’s mission is to make spine surgery safer. Its primary
objective is to establish its proprietary DSG™ (Dynamic Surgical
Guidance) technology as the global standard of surgical care, initially
for safer screw placement in spine surgery and then in other surgeries.
PediGuard®, the first device designed using DSG was co-invented by
Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain
Vanquaethem, Biomedical Engineer. It is the world’s first and only
handheld device capable of alerting surgeons to potential pedicular or
vertebral breaches. Over 45,000 surgical procedures have been performed
worldwide with PediGuard. Numerous studies published in peer-reviewed
medical and scientific journals have demonstrated the multiple benefits
that PediGuard delivers to patients, surgical staff and hospitals. In
2015, SpineGuard started to expand the applications of DSG into pedicle
screws through partnerships with innovative surgical companies in France
and the US. SpineGuard has offices in San Francisco and Paris.
For further information, visit www.spineguard.com.
Disclaimer
The SpineGuard securities may not be offered or sold in the United
States as they have not been and will not be registered under the
Securities Act or any United States state securities laws, and
SpineGuard does not intend to make a public offer of its securities in
the United States. This is an announcement and not a prospectus, and the
information contained herein does and shall not constitute an offer to
sell or the solicitation of an offer to buy, nor shall there be any sale
of the securities referred to herein in the United States in which such
offer, solicitation or sale would be unlawful prior to registration or
exemption from registration.